Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

 Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

Shots:

  • Qiagen’s QIAseq SARS-CoV-2 primer panel provides optimized, single-day workflows to prepare libraries for sequencing as researchers use NGS to track changes in the viral genome
  • The two-step process uses advanced QIAseq technologies to conduct reverse transcription and cDNA synthesis from a viral RNA sample, then generate libraries compatible with Illumina sequencing platforms
  • The solution aims to accelerate research into COVID-19 prevention and treatment by enabling deeper and more holistic insights into the biology of SARS-CoV-2

Click here ­to­ read full press release/ article | Ref: Qiagen | Image: Euronews

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post